HRTX icon

Heron Therapeutics
HRTX

Overview Fund Activity

99 hedge funds and large institutions have $690M invested in Heron Therapeutics in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 10 closing their positions.

Holders
99
Holders Change
+8
Holders Change %
+8.79%
% of All Funds
2.48%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
18
Increased
34
Reduced
30
Closed
10
Calls
$21.1M
Puts
$8.42M
Net Calls
+$12.7M
Net Calls Change
+$7.52M

Top Buyers

1
BC
1
Broadfin Capital
New York
$51.1M
2
HCMT
2
Highland Capital Management (Texas)
Texas
$20.5M
3
JHIU
3
Janus Henderson Investors US
Colorado
$59.9M
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$6.86M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$6.37M

Top Sellers

1
Invesco
1
Invesco
Georgia
$7.67M
2
PHS
2
PFM Health Sciences
California
$35.8M
3
RI
3
RTW Investments
New York
$0
4
BBA
4
Baker Bros. Advisors
New York
$31.2M
5
Asset Management One
5
Asset Management One
Japan
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BC
101
Boxer Capital
California
– -$3.45M -200,000 Closed
FAM
102
Fred Alger Management
New York
– -$1.41M -81,903 Closed
CS
103
Candriam SCA
Luxembourg
– -$1.03M -60,000 Closed
TI
104
Turner Investments
Pennsylvania
– -$782K -45,390 Closed
FO
105
FT Options
Illinois
– -$516K -29,937 Closed
UBS AM
106
UBS AM
Illinois
– -$262K -15,200 Closed
ACH
107
ArrowMark Colorado Holdings
Colorado
– -$38K -2,232 Closed
KF
108
Krilogy Financial
Missouri
– -$3K -200 Closed
1 2 3 4
5